FDA Inspection 1224386 — Eagle Labs Inc.

Eagle Labs Inc. — FEI 3005552050

The FDA completed an inspection of Eagle Labs Inc. on Dec 6, 2023 in Seminole, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 6, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Seminole, FL (United States)

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed
135821 CFR 211.100(b)SOPs not followed / documented